- Supported exchanges /
- NASDAQ /
- CDTTW.NASDAQ
Conduit Pharmaceuticals Inc. (CDTTW NASDAQ) stock market data APIs
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Conduit Pharmaceuticals Inc. Financial Data Overview
0.0139 | |
0.0076 | |
- | |
0.0139 | |
0.0076 | |
0.0056-0.16 | |
0 | |
0 | |
0 | |
2.086 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Conduit Pharmaceuticals Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Conduit Pharmaceuticals Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Conduit Pharmaceuticals Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: